Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc.
1. Biorad Medisys launches Medtimo Inc. in the U.S. market. 2. Medtimo focuses on obesity treatments and neurological rehabilitation. 3. Acquisition of ReShape Lifesciences boosts product portfolio. 4. FDA-approved products like Obalon® balloon enhance market credibility. 5. Expansion indicates Biorad's commitment to U.S. growth.